
    
      Study Design: Single institution, open-label, randomized study

      Study Device: Pleurx Catheter

      Treatment Plan: Cohort A: 15 patients treated with standard therapy (therapeutic paracentesis
      +/- diuretics)

      Cohort B: 15 patients treated with peritoneal Pleurx catheter

      Duration of Participation: Patients will be followed for one year, or until death, whichever
      comes first.

      Primary Outcome: Safety of the Pleurx catheter procedure or paracentesis

      Secondary outcomes: Overall complications, quality of life, overall survival, and symptom
      control
    
  